# NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

> **NCT06452394** · PHASE2 · RECRUITING · sponsor: **Swiss Cancer Institute** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Doxycyclin

## Key facts

- **NCT ID:** NCT06452394
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-16
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06452394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06452394, "NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06452394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*